Project

biotechnology netherlands

Targeting RNA Dicing

Modular Therapeutics is addressing one of the biggest challenges in medicine: many patients do not respond to existing treatments because their disease is driven by unique molecular changes that current drugs cannot target, often due to an insufficient understanding of the biological impact of these mutations. Our innovation is based on a newly discovered biological process called RNA dicing – a natural way in which cells cut and rewire genetic messages. We have found that this process can produce protein variants that play a key role in cancer, immune disorders, and other diseases.

Our technology combines advanced genetic analysis with machine learning models to detect these disease-causing variants in patient samples. This enables us to match patients with the most effective existing medicines or to guide the development of entirely new treatments. The modular nature of our approach means it can be quickly adapted to different diseases, potentially benefiting millions of patients worldwide.

Within the Biotech Booster program, we will refine our detection technology, focusing on abundant oncogenic mutations in endometrial cancer, validate it using patient samples, and lay the groundwork for personalized therapies. Our ultimate goal is to accelerate the path from discovery to treatment, improving patient outcomes and reducing healthcare costs.

Project team

Frédéric Amant (Project Leader, NKI-AVL), Yuval Malka (Co-lead Modular, Therapeutics), Willem-Jan Keune (Business Developer, NKI-AVL & Biotech Booster)

Project Number

BIOB25006

Year granted

2025

Status

Ongoing

Applicant

Netherlands Cancer Institute

Funding

€ 199.745

Sector/Industry

Health & Pharma

SDG's

Good health and well-being (SDG 3)

Thematic Cluster

TC5: Vaccines, Small Molecules, Discovery & Development Platforms

Level

Level 1
Molecuul

2025

Year granted

Netherlands Cancer Institute

Applicant

€ 199.745

Project funded
Project story

Plant Beams: breaking through the plant barrier

The question that started Plant Beams For over ten years, David Fernández Rivas has worked on a technology that uses

Plant Beams: breaking through the plant barrier
Project story

SideroFORCE: Tricking bacteria to heal infection

We interviewed Wim Velema, projectleader of Biotech Booster project SideroFORCE, which joined our program in 2025. At sixteen, Wim liked

SideroFORCE: Tricking bacteria to heal infection
IBB

Behind the Bootcamp: Meet the IBB26 Coaches

Building an industrial biotech venture takes more than a great scientific idea. It requires the ability to challenge assumptions, make

Behind the Bootcamp: Meet the IBB26 Coaches
Project story

From Luggage Tags to Better Food

From fragmented DNA to better food on our plates. We interviewed Biotech Booster project Haplotagging to learn more about their

From Luggage Tags to Better Food
Impact developer portrait

The Innovation Journey at the Universities of Applied Sciences

Impact Developers help researchers turn their ideas into innovations that impact society. They connect researchers with companies and other partners

The Innovation Journey at the Universities of Applied Sciences
Alumni Column

Alumni column: Patrick Dekker from iProtics

On both sides of the table. Some people know Biotech Booster from the outside. Others experience it from the inside,

Alumni column: Patrick Dekker from iProtics
Citaat

Biotech Booster helps us through funding and by providing us with a network to validate where we can make the best impact with our new analysis device.

Biotechnology netherlands

Carlos de Lannoy

Constellate

Citaat

What we look forward to most is leveraging the extraordinary network of Biotech Booster that we need to get foot in the market, get know-how, and understanding the competitive field which is necessary for setting up successful operations.

Biotechnology netherlands

Pim Schaasberg & Martin Pabst

ProteoT

Moleculen

Newsletter

Receive monthly updates about our community!

Subscribe to our newsletter